Compare OPEN & MMED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OPEN | MMED |
|---|---|---|
| Founded | 2014 | 1983 |
| Country | United States | United States |
| Employees | N/A | 2800 |
| Industry | Real Estate | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.9B | 4.3B |
| IPO Year | 2020 | 2026 |
| Metric | OPEN | MMED |
|---|---|---|
| Price | $4.44 | $16.92 |
| Analyst Decision | Sell | Strong Buy |
| Analyst Count | 3 | 10 |
| Target Price | $1.67 | ★ $22.56 |
| AVG Volume (30 Days) | ★ 64.2M | 1.1M |
| Earning Date | 05-07-2026 | 06-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $4,371,000,000.00 | N/A |
| Revenue This Year | $3.04 | $15.99 |
| Revenue Next Year | $53.82 | $10.00 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.70 | $10.65 |
| 52 Week High | $10.87 | $17.86 |
| Indicator | OPEN | MMED |
|---|---|---|
| Relative Strength Index (RSI) | 44.34 | 67.21 |
| Support Level | $4.16 | $14.70 |
| Resistance Level | $5.58 | N/A |
| Average True Range (ATR) | 0.39 | 0.88 |
| MACD | -0.03 | 0.11 |
| Stochastic Oscillator | 7.95 | 88.11 |
Opendoor Technologies Inc is an end-to-end real estate platform enabling customers to sell and buy a home online. Its product offerings include Sell to Opendoor, its core product where sellers sell their homes directly to the company, and it resells those homes to buyers; List with Opendoor, for customers to list their homes with a partner agent; and Opendoor Marketplace, a capital-light marketplace offering that connects home sellers with both institutional and retail buyers. In addition to these products, the company also offers its customers integrated title insurance and escrow services through its subsidiaries. A vast majority of the company's revenue is generated by its core product offering, where it acquires homes directly from sellers and resells those homes to buyers.
Minimed Group Inc is a scaled medical technology company that develops, manufactures, and markets a comprehensive suite of solutions for the management of diabetes. It serves PWD who require intensive insulin therapy, which represents all people with T1D and a subset of those with T2D. The company's platform of simple and clinically effective solutions for PWD requiring insulin therapy includes Automated Insulin Delivery (AID) Systems and Smart Multiple Daily Injection (MDI) Systems. It derives revenue from the sale of products focused on diabetes management, including insulin pumps, continuous glucose monitoring systems and sensors, and smart insulin pens. Geographically, it operates in the USA and the Rest of World, with the majority of revenue derived from the Rest of World.